Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.

J Exp Clin Cancer Res · 2023 · PMC10540318 · PMID 37770957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Nevertheless, BALB-neuT/xCT null mice showed a trend of reduction in the incidence of lung metastasis (Fig. 1 C) when culled for ethical reasons at 20–25 weeks of age (Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.